Literature DB >> 15297836

Iatrogenic subclavian artery pseudoaneurysm causing airway compromise: treatment with percutaneous thrombin injection.

Rakesh Jeganathan1, Denis W Harkin, Patrick Lowry, Bernard Lee.   

Abstract

Central venous cannulation is an increasingly common diagnostic and therapeutic procedure in modern medical practise. Inadvertent iatrogenic injury to an adjacent major artery during attempted central venous cannulation is an uncommon but potentially lethal complication. If injury leads to pseudoaneurysm formation, complications may arise from mass effect, embolism, or even rupture with continued hemorrhage. Traditional surgical repair of these lesions is often difficult, especially if access within the thorax is required in patients at high risk. We present a case report of successful management of a large subclavian artery pseudoaneurysm with the new approach of percutaneous thrombin injection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297836     DOI: 10.1016/j.jvs.2004.03.049

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  4 in total

1.  Subclavian artery injury secondary to clavicular plate fixation: a novel operative approach.

Authors:  Kalpa G Perera; Celia Clifford; Lachlan Maddock
Journal:  J Surg Case Rep       Date:  2015-04-15

2.  Balloon-Assisted Percutaneous Thrombin Injection for Treatment of Iatrogenic Left Subclavian Artery Pseudoaneurysm in a Critically Ill COVID-19 Patient.

Authors:  Hassan Al-Thani; Ahmed Hussein; Ahmed Sadek; Ali Barah; Ayman El-Menyar
Journal:  Case Rep Vasc Med       Date:  2021-10-07

3.  Resection of a giant mycotic left subclavian pseudoaneurysm.

Authors:  Sidney T Le; Genna Beattie; Shahram Aarabi
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-12-23

4.  Traumatic axillary artery pseudoaneurysm treated with intravascular balloon occlusion and percutaneous thrombin injection.

Authors:  Maria Carratola; Priti Parikh; Kathryn Tchorz; Shannon Kauffman
Journal:  Radiol Case Rep       Date:  2015-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.